Clinical Trial Update: Hepatic Function During and Following Three Days of Acetaminophen Dosing in Alcoholics [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating hepatic function during and after three days of acetaminophen dosing in individuals with alcohol use disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Liver Diseases

Drugs mentioned

• Acetaminophen (Acetaminophen)

Snippet

Sponsor: Denver Health and Hospital Authority | Conditions: Alcohol Related Disorders | Phase 4 | Status: COMPLETED